Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells

Abstract

An object is to provide a novel medical use of adipose tissue-derived mesenchymal stem cells. It was discovered that adipose tissue-derived mesenchymal stem cells (ASC) promote improvement of erectile dysfunction and recovery of the urge to urinate (improvement of sensory disorders of the lower urinary tract). On the basis of the discovery, a cell preparation containing adipose tissue-derived mesenchymal stem cells, which is effective to erectile dysfunction or sensory disorders of the lower urinary tract, is provided. In one embodiment, adipose tissue-derived mesenchymal stem cells and body fat are used in combination.

1 - 12 . (canceled) 
     
     
         13 . A use of adipose tissue-derived mesenchymal stem cells for producing a cell preparation for sensory disorders of the lower urinary tract, the use comprising administering a cell preparation comprising human adipose tissues-derived mesenchymal stem cells to the external urethral sphincter muscle and/or to the membranous urethra of external urethral sphincter muscle of a patient suffering from sensory disorders of the lower urinary tract. 
     
     
         14 . A use of adipose tissue-derived mesenchymal stem cells and body fat, for producing a cell preparation for sensory disorders of the lower urinary tract, the use comprising administering therapeutically effective amounts of adipose tissue-derived mesenchymal stem cells and body fat to the external urethral sphincter muscle and/or to the membranous urethra of external urethral sphincter muscle of a patient suffering from sensory disorders of the lower urinary tract.